DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Ultrasound Homepage

Radiology practices are willing to pay more for a better RIS Survey finds customizable systems with better workflow justify expense to providers

Ultrasound with 'cheap' blood test improves early-stage liver cancer detection by 40 percent May become standard practice

Study finds patients lack info about imaging exams Researchers uncover what they want to know

FUJIFILM SonoSite donates point-of-care ultrasound to Iraqi hospital Equipment and building devastated by ISIS military offensive

INSIGHTEC and Virginia Tech to develop brain disorder treatments with Exablate Neuro First nonclinical research environment to use Exablate Neuro

GE unveils its Versana Essential ultrasound system Affordable option for primary care physicians

Ultrasound-based technology may be able to treat cancer Can it replace radiotherapy one day?

Hitachi Healthcare Americas jumps into health IT with VidiStar acquisition Deal will enhance ultrasound service, product portfolio

AIUM Task Force develops curriculum to standardize ultrasound training for OB/GYN residents

Asia-Pacific imaging market to grow at a CAGR of 10 percent through 2021 Technological advancement is one of the main drivers

Concept illustration of a cart based
ultrasound and TAEUS platform
courtesy: ENDRA

GE and ENDRA extend agreement to advance liver ultrasound

by John W. Mitchell , Senior Correspondent
The increasing worldwide incidence of liver disease, driven by obesity, diabetes and hepatitis, is pushing imaging companies to develop new technology for earlier diagnosis. ENDRA has renewed an agreement with GE Healthcare to continue work on a standard CT application.

“Over one billion people are affected by fatty liver disease (NAFLD), which can progress to inflammation (NASH), then fibrosis scarring, then cirrhosis or cell death and then to cancer,” Francois Michelon, CEO at ENDRA Life Sciences told HCB News. “There are no practical tools for diagnosing NAFLD and NASH.”

Story Continues Below Advertisement

Ventilators Plus -The Easy #1 Choice In Ventilator Sales, Rentals & Support

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY, SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7. Call 888-889-2992.



To remedy this, EDRA has developed Thermo Acoustic Enhanced Ultrasound (TAEUS) that will enable standard ultrasound to detect such liver diseases in the early stage, while it is still reversible. Currently, the company said, ultrasound can only indicate liver diseases in the late stages.

ENDRA and GE Healthcare are working to deploy the technology in Europe by the end of 2018. Michelon said the expected cost of the unit would be about $40,000.

“We believe that ENDRA's technology has the potential to bring significant new capabilities to ultrasound - which aligns well with GE Healthcare's mission of increasing access to high-quality, cost-effective health care,” said Brian McEathron, GE Healthcare's vice president and general manager for General Imaging Ultrasound. “We're very excited about completing the final steps toward commercialization of ENDRA's TAEUS fatty liver product."

Michelon said TAUES is safer and more economical than other standard protocols. MR/CT technology, he noted, is expensive to acquire at between $1-3 million. Surgical biopsy is another alternative, but the procedure is also expensive, painful and carries the risk of complications. And blood liver enzyme level testing is unreliable he said, with about half of all NAFLD patients testing normal.

“The key benefit of ENDRA's technology is that it leverages conventional ultrasound, which is widely accepted as safe, cost-effective, easy-to-use, and broadly available. This broadens access to better health care,” said Michelon.

TAEUS will also offer more widespread diagnostic testing for liver disease, according to Michelon. Physicians will gain a new, cost-effective, and safe tool to address the growing crisis of liver disease. They will be able to deliver better health care to more people in clinics, community hospitals, private practices, patient bedsides – wherever ultrasound is used.

“By diagnosing NAFLD earlier on ultrasound, insurers will start reducing downstream costs of advanced liver disease, such as expensive inpatient care and liver transplants, as well as avoid costs of more expensive diagnostic tools such as CT and MR,” said Michelon.

ENDRA is also developing several other software applications to enhance ultrasound. This includes an application to indicate tissue temperature with ultrasound during energy-based surgeries to treat cancer and heart conditions.

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED